Stock(600222)
Hot line:010-61006450
EN
简体中文
Home
About Leadingpharm
Company Introduction
Company History
Team
Group Frame
Honors
Culture
Partners
CMC
Platform Introduction
API R&D Platform
Formulation R&D Platform
Analytical Testing Platform
IVIVR Platform
CRO
Platform Introduction
Services
Base Resources
MAH
Leadingpharm MAH Platform
Project Initiation Service
Drug Administration Service
CDMO
Quality Integration Service
News
Company News
Join
Talent Development
Join Us
Contact
News
Understand the latest news of Leadingpharm
Company News
01
2020-04
体内外相关性研究在口服固体制剂仿制过程中的应用
对于能够产生全身作用的药物而言,口服固体制剂由于患者顺应性高、携带方便和生产成本低等特点,是临床首选的给药途径。目前,仿制口服固体制剂仍在临床应用中占据主导地位,评价仿制制剂与原研制剂的一致性
1
2
3
4
5
010-61006450